Shares of SBC Medical Group (NASDAQ:SBC) soared more than 37% on Friday after the health clinic management leader reported strong quarterly growth figures and announced a new artificial intelligence (AI) alliance.
Image source: Getty Images.
Missed AI’s “Act 1”? Act 2 Could Be 15x Bigger. Most investors think they missed the AI boat because they didn’t buy Nvidia in 2005. But according to our analysts, we’re only at the end of “Act 1″—the R&D phase. “Act 2” is the global rollout. Continue »
Healthy growth
SBC’s revenue jumped 35% year over year to $59 million in the third quarter. The gains were driven by new clinic openings and service fee increases.
SBC’s network grew by 36 clinics over the past year, bringing its total to 293 locations as of Sept. 30. In turn, patient visits over the trailing 12 months increased 9% to 7.06 million.
New services and equipment upgrades are also leading people to spend more at these clinics. Average spend per visit rose 4% to $290.
“Our goal is not simply to add locations,” CEO Yoshiyuki Aikawa said. “We aim to raise productivity and profitability at the clinics we support while expanding the network efficiently.”
As a leading Medical Services Organization (MSO), SBC provides management and operational support to clinical networks in Japan, the U.S., and other international markets. Services include customer acquisition, staffing, and technology upgrades.
In this way, SBC enables physicians to focus on patient care rather than the administrative aspects of their clinics.
SBC’s business model is also highly profitable. Its income from operations surged 66% to $26 million. That’s an operating margin of 45%.
AI could drive profits even higher
To make its clinic network even more lucrative, SBC is partnering with NeuroBrain Dynamics to co-develop medical AI tools to deliver more personalized customer recommendations and further streamline operational processes.
“Across a 287-clinic network, even micro efficiencies scale into significant potential earnings power,” Aikawa said. “By blending SBC Medical’s deep, on-the-ground operational data with NeuroBrain Dynamics’ proven enterprise AI execution, we are positioning our business to achieve improved operating leverage while delivering exceptional value to our customers, clinic partners, and shareholders.”
Should you buy stock in Sbc Medical Group right now?
Before you buy stock in Sbc Medical Group, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Sbc Medical Group wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004… if you invested $1,000 at the time of our recommendation, you’d have $338,083!* Or when Nvidia made this list on April 15, 2005… if you invested $1,000 at the time of our recommendation, you’d have $1,021,163!*
Now, it’s worth noting Stock Advisor’s total average return is 830% — a market-crushing outperformance compared to 209% for the S&P 500. Don’t miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of November 13, 2026.
Joe Tenebruso has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
